
1. plos pathog. 2010 dec 23;6(12):e1001236. doi: 10.1371/journal.ppat.1001236.

structural basis apoptosis inhibition epstein-barr virus bhrf1.

kvansakul m(1), wei ah, fletcher ji, willis sn, chen l, roberts aw, huang dc,
colman pm.

author information: 
(1)the walter eliza hall institute medical research, parkville, victoria, 
australia.

epstein-barr virus (ebv) associated human malignancies, especially 
affecting b cell compartment burkitt lymphoma. virally encoded
homolog mammalian pro-survival protein bcl-2, bhrf1 contributes viral
infectivity lymphomagenesis. addition pro-apoptotic bh3-only
protein bim, key target lymphoid cells, bhrf1 also binds selective
sub-set pro-apoptotic proteins (bid, puma, bak) expressed host cells. a
consequence bhrf1 expression marked resistance range cytotoxic
agents particular, show expression renders mouse model of
burkitt lymphoma untreatable. current small organic antagonists bcl-2 do
not target bhrf1, structures complex bim bak shown will
be useful guide efforts target bhrf1 ebv-associated malignancies, 
are usually associated poor clinical outcomes.

doi: 10.1371/journal.ppat.1001236 
pmcid: pmc3009601
pmid: 21203485  [indexed medline]

